Dipender is a clinician scientist, who trained in Medical Sciences at the University of Oxford and was awarded Distinction for his BM BCh. He went on to become a specialist registrar in clinical pharmacology and therapeutics at Imperial College Healthcare NHS Trust, and in 2013 became an Honorary Clinical Lecturer at Imperial College London. Most recently, Dipender has followed his research interests in Mendelian randomisation to identify causal risk factors and therapeutic targets for cardiovascular diseases, successfully defending his PhD thesis in Dec 2019. He has over 50 peer-reviewed manuscripts including 16 first author papers from his PhD. This includes work identifying genetic variants to proxy the effect of antihypertensive, anticoagulant and anti-inflammatory drugs.
et al., 2023, Genetically Predicted Sleep Traits and Functional Outcome After Ischemic Stroke: A Mendelian Randomization Study., Neurology, Vol:100, Pages:e1159-e1165
et al., 2023, Investigating modifiable pathways in psoriasis: A Mendelian randomization study., J Am Acad Dermatol, Vol:88, Pages:593-601
et al., 2023, Mendelian randomization and clinical trial evidence supports TYK2 inhibition as a therapeutic target for autoimmune diseases., Ebiomedicine, Vol:89
et al., 2023, Gastrointestinal Consequences of Type 2 Diabetes Mellitus and Impaired Glycemic Homeostasis: A Mendelian Randomization Study., Diabetes Care
et al., 2023, Circulatory proteins relate cardiovascular disease to cognitive performance: a Mendelian randomisation study, Frontiers in Genetics, ISSN:1664-8021